Owlet secures CDSCO approval for Dream Sock and plans to launch in India in early 2026: Lehi, Utah Friday, October 17, 2025, ...
Chemist Lutz Ackermann receives Bayer Foundation’s Hansen Family Award: Leverkusen Friday, October 17, 2025, 13:00 Hrs [IST] ...
Curium Group, PeptiDream & PDRadiopharma begin patient enrollment in registrational clinical trial of 64Cu-PSMA-I&T for prostate cancer in Japan: Paris, France Friday, October 17, ...
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights: San Diego Friday, October 17, 2025, 17:00 Hrs [IST] Illu ...
AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme
AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme: United Kingdom Friday, October 17, 2025, 16:00 Hrs [IST] Artificial int ...
SK bioscience files for first-in-human trial of universal coronavirus vaccine, GBP511 phase 1/2 study in Australia: Republic of Korea Friday, October 17, 2025, 15:00 Hrs [IST] SK ...
Roche presents major advances for its sequencing by expansion technology, including a new Guinness World Record, at the ASHG conference 2025: Basel Friday, October 17, 2025, 12:00 ...
Suraksha Clinic and Diagnostics conducts East Zone AMBI workshop on capillary electrophoresis and immunotyping: Our Bureau, Mumbai Friday, October 17, 2025, 13:45 Hrs [IST] Suraks ...
Novartis Fabhalta meets phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy: Basel Friday, October 17, 2025, 10:00 Hrs [IST] Novartis announ ...
Biorad Medisys accelerates vascular and stroke care through new partnerships and technology: Our Bureau, Mumbai Friday, October 17, 2025, 16:15 Hrs [IST] Biorad Medisys Pvt. Ltd.
The treatment group showed significant improvements in key clinical and metabolic biomarkers from the third day of therapy, suggesting that this technique may represent a promising adjunctive approach ...
Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio: Ingelheim, Germany Friday, October 17, 2025, 11:00 Hrs [IST] Boehringer Ingelheim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results